Increasing postpartum use of GLP-1 receptor agonists - EurekAlert!
Daily oral GLP-1 pill exhibits promising results in treatment options for adults with diabetes and obesity in trial led by UTHealth Houston researcher - EurekAlert!
GLP-1 agonists: Addressing side effects of weight loss drugs - EurekAlert!
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
Research alert: GLP-1 drugs linked to dramatically lower death rates in colon cancer patients - EurekAlert!
GLP-1 drugs effective for weight loss, but more independent studies needed - EurekAlert!
A turning point in addiction psychiatry? GLP-1 drugs go far beyond weight loss and show a surprising ability to tame cravings for everything from alcohol to gambling.
Utah chemists discover enzyme that could help build next-generation GLP-1 drugs - EurekAlert!
GLP-1 agonists pose emerging challenge for PET-CT imaging, study finds - EurekAlert!
New oral GLP-1 drugs could offer more options for weight loss
Alpha cells moonlight as secret GLP-1 factories - EurekAlert!
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines - EurekAlert!
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity - EurekAlert!
Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes - EurekAlert!
GLP-1 weight-loss drugs pose hidden risks for young women - EurekAlert!
GLP-1 RAs and cardiovascular and kidney outcomes by body mass index in type 2 diabetes - EurekAlert!
As insurers struggle with GLP-1 drug costs, some seek to wean patients off
GLP-1 drugs reduce risk of death and hospitalization in patients with heart failure - EurekAlert!
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
